A ChIP assay indicated that TFAP2C could bind to the P2 and P3 binding sites in the promoter region of ROCK1 and P1 and P2 binding sites in ROCK2 in CRC cells (Fig. 7d and e, and Additional file 14: Figure S7A and B). The gene discussed is ROCK2; the disease is colorectal carcinoma.